CompletedPhase 1NCT07038941

Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Beijing Dayspring Pharmaceutical Technology Co., Ltd
Principal Investigator
Yi Fang, MD, PhD
Peking University People's Hospital
Intervention
CG2001(drug)
Enrollment
44 enrolled
Eligibility
18-65 years · MALE
Timeline
20242024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07038941 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials